International Conference on Central Nervous System - Drugs Effects & Novel Drug Development

Venue: DoubleTree by Hilton

Location: Philadelphia, United States

Event Date/Time: Sep 05, 2012 End Date/Time: Sep 07, 2012
Registration Date: Jul 23, 2012
Early Registration Date: Apr 10, 2012
Abstract Submission Date: Apr 05, 2012
Report as Spam


OMICS Group invites all the participants across the globe to attend the International Conference on Central Nervous System - Drugs Effects & Novel Drug Development during September 5-7, 2012 at DoubleTree by Hilton Philadelphia, USA.
Central Nervous System-2012 is a remarkable event which brings together all the leading universities, Central Nervous System researchers as well as institutions, making the conference a perfect platform to share experiences, foster collaborations across industry and academia and also evaluate emerging technologies across the globe.
International Conference on Central Nervous System - Drugs Effects, Novel Drug Development will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Research of Central Nervous System across the world. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies.
Conference Highlights the following topics:
• Disorders related to CNS • Behavioral Neurology
• Clinical Neurophysiology • Oncology of Central Nervous System
• Neurodegenerative Diseases • Remedies for CNS & Neurological Disorders
• CNS Biomarkers • Clinical Trials on CNS
• Drug Metabolism in Drug Design and Drug Interactions
• Neurological drug targets CNS & Neurological Disorders

Important Dates
Abstract submission opens on 7th November 2011
Registration opens on 21st November 2011
Abstract submission closes on 5th April 2012
Early bird Registration closes on 10th April 2012
Deadline for Registration 23rd July 2012
On spot Registration 5th September 2012

Please submit your abstract to any of the following tracks
Track 1: Drug Interactions
Track 1-1: Beneficial Drug Interactions
Track 1-2: Types Of Drug Interactions
Track 1-3: Epidemiology Of Drug-Drug Interactions
Track 1-3-1: Pharmacodynamics
Track 1-3-2: Pharmacokinetics
Track 2: Drug Metabolism in Drug Design
Track 2-1: Metabolism Mediated DrugDrug Interactions
Track 2-2: Enzyme Kinetics
Track 2-3: Role of Drug Metabolism in Drug Development
Track 3: Disorders related to CNS
Track 3-1: Acoustic Neuroma
Track 3-2: Encephalitis
Track 3-3: Juvenile Huntington Disease
Track 3-4: Spinal Meningitis
Track 3-5: Motor Neuron Disease
Track 3-6: Hydrocephalus
Track 3-7: Normal Pressure Hydrocephalus
Track 4: Neurological drug targets CNS & Neurological Disorders
Track 4-1: Properties of Drug Molecules
Track 4-2: Target Discovery
Track 4-3: Target Validation
Track 4-4: Lead Optimization
Track 4-5: Drug Delivery
Track 4-6: Food and Drug Adminstration(FDA)
Track 4-7: Clinical Trails
Track 4-8: Pharmacokinetics
Track 5: Behavioral Neurology
Track 5-1: Agnosias
Track 5-2: Amnesias
Track 5-3: Anosognosia
Track 5-4: Aphasias
Track 5-5: Dementias
Track 5-6: Hemispatial Neglect
Track 5-7: Traumatic Brain Injury
Track 6: Clinical Neurophysiology
Track 6-1: Electromyography
Track 6-2: Electroencephalography
Track 6-3: Evoked potentials
Track 6-4: Polysomnography
Track 7: Oncology of Central Nervous System
Track 7-1: Signs and Symptoms
Track 7-2: Cause
Track 7-3: Pathophysiology
Track 7-4: Diagnosis
Track 7-5: Treatment
Track 7-6: Prognosis
Track 7-7: Epidemology
Track 8: Neurodegenerative Diseases
Track 8-1: Alzheimer's Disease
Track 8-2: Parkinsonism
Track 8-3: Down Syndrome
Track 8-4: Schizophrenia
Track 8-5: Autism
Track 9: Remedies for CNS & Neurological Disorders
Track 9-1: Medicinal Chemistry
Track 9-2: Pharmacology
Track 9-3: Molecular Biology
Track 9-4: Disorders e.g. Disease Specific Proteins, Receptors, Enzymes, Genes
Track 10: CNS Biomarkers
Track 10-1: Supporting CNS Drug Development Using Biomarkers
Track 10-2: Challenges in CNS Biomarkers
Track 10-3: CerebroSpinalFluid Biomarkers
Track 10-4: Industry / Academic Collaborations
Track 10-5: Anti Amyloid Therapies for Alzheimer's Disease
Track 10-6: Neuro Imaging
Track 10-7: Technology Case Studies for CNS
Track 11: Clinical Trials on CNS
Track 11-1: Latest Developments in MS, PD and AD Clinical Development
Track 11-2: Biomarkers Implication in Clinical Trials
Track 11-3: Participant Recruitment and Retention Issues in CNS Clinical Trials
Track 11-4: Schizophrenia and Depression: Specific Considerations
Track 11-5: Current Challenges in Translational CNS Research
Track 11-6: Facilitating and Establishing Industry and Academic Partnering
Track 11-7: Early Phase Development Trials in CNS
Track 12: Current Drug Discovery Technologies
Track 12-1: Immunofluorescence into Drug Discovery
Track 12-2: Immunoelectron Microscopic Localization of Medicinal Substance
Track 12-3: Determination of Active Compound Using MAb
Track 12-4: microRNA in Drug Discovery: From Therapeutics to Biomarkers
Track 12-5: Planning Clinical Treatments from Pharmacologic Data
Welcome to the Official Attendee Housing Site for the International Conference & Exhibition on Central Nervous System, will be Held in the beautiful and exciting city of Philadelphia, USA. The conference will take place in the following dates and locations.
Conference Dates: September 5-7, 2012
DoubleTree by Hilton
237 S Broad St, Philadelphia, Pennsylvania 19107, United States
Phone:+1 215-893-1600
Fax: 1-215-893-1663


237 S Broad St, Philadelphia, Pennsylvania 19107, United States
United States